Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity

Explore clinical trials studying Hypersensitivity. Study availability and eligibility vary by location and protocol.

6,798 public trials 656 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity trial results

Active, not recruiting

Study in Paediatric Patients With Atopic Dermatitis Treated With Dupilumab in Spain

NCT06415175

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Investigational Site Number : 7240004 Santiago de Compostela, A Coruña [La Coruña], Spain
  • Investigational Site Number : 7240006 Esplugues de Llobregat, Barcelona [Barcelona], Spain
  • Investigational Site Number : 7240005 Oviedo, Principality of Asturias, Spain
  • Investigational Site Number : 7240008 Seville, Sevilla, Spain
View all 15 locations
View Trial Details
Active, not recruiting

Investigating Dupilumab's Effect in Asthma by Genotype

NCT03694158

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Boston Children's Hospital Boston, Massachusetts, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Henry Ford Health System Detroit, Michigan, United States
  • Montefiore Einstein Clinical Research Center The Bronx, New York, United States
View Trial Details
Active, not recruiting

Safety and Efficacy of Upadacitinib in Combination With Topical Corticosteroids in Children From 2 to Less Than 12 Years of Age in Japan With Moderate to Severe Atopic Dermatitis

NCT06701331

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Central Clinic - Nagoya /ID# 269205 Nagoya, Aichi-ken, Japan
  • Fujita Health University Hospital /ID# 269201 Toyoake, Aichi-ken, Japan
  • Miyata Dermatology Clinic /ID# 269200 Matsudo-Shi, Chiba, Japan
  • Hoshikuma Dermatology ・ Allergy Clinic /ID# 270192 Fukuoka, Japan
View all 25 locations
View Trial Details
Active, not recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Immunogenicity of APG777 in Adults With Asthma

NCT06920901

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Investigational Site La Jolla, California, United States
  • Investigational Site Long Beach, California, United States
  • Investigational Site San Jose, California, United States
  • Investigational Site Torrance, California, United States
View Trial Details
Active, not recruiting

A Study to Investigate the Effect on Lung Function of BDA Formulated With a Next Generation Propellant Compared With an Approved Asthma Treatment (BDA With HFA Propellant) in Participants With Asthma

NCT06502366

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Research Site Mobile, Alabama, United States
  • Research Site Sheffield, Alabama, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Little Rock, Arkansas, United States
View all 128 locations
View Trial Details
Active, not recruiting

Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE

NCT06669754

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Study Site Little Rock, Arkansas, United States
  • Study Site San Diego, California, United States
  • Study site Santa Monica, California, United States
  • Study site Walnut Creek, California, United States
View all 56 locations
View Trial Details

Related conditions